Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
IBM Agrees to Pay Government $17 Million in DEI Settlement 
Viewpoint: Why Brokers Have Little to Fear and Everything to Gain From AI 
Wall Street Banks Try Out Anthropic’s Mythos 
Convicted Insurance Mogul Lindberg Should Pay $1.6B Restitution to Companies 
